Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Interview with Tripp posted today
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(64)
•••
Comment by gojotv!on Apr 14, 2021 7:31pm
150 Views
Post# 32997884

RE:RE:RE:Interview with Tripp posted today

RE:RE:RE:Interview with Tripp posted today*facepalm! ...
It's becoming clear to me that I'm excited about this stock because I understand this business. Here it is again...

https://stockhouse.com/companies/bullboard?symbol=t.szls&postid=32974652


cactuseskimo wrote:

Other than wanting to give Tripp a smack on the back of the head, it was a decent interview. My question is though - why did this information about needing a prescription for cancer testing seemingly come at us last minute? Like, shouldn't have this been known all along? It would have been much less of a blindside CC had that little tidbit been known to everyone.

 

Nailbiter1 wrote: Thanks Rockin' Jonny.
The more I hear about this new pivot / partnership / acquisition, the more it makes absolute sense. Very exciting times.
 

 

 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities